Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / CAGE

CAGE

Basics

Aliases:
This biomarker is also known as:
  • CTAG3,
  • CAGE-1,
  • bA69L16.7,
  • CT95,
  • cancer/testis antigen 95,
  • CT3,
  • cancer/testis antigen 3,
  • cancer-associated gene 1 protein,
  • CAGE1,
  • Cancer/testis antigen 3,
  • cancer antigen 1,
  • cancer/testis antigen gene 1,

View in BioMuta

Description…

Promoter hypermethylation of the CAGE1 gene is related to plays a crucial role during the phenotypical morphogenesis of several types of cancer. CAGE1 shows testis-specific expression in normal tissues, but wide expression among cancer tissues and cell lines.

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: CAGE1

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place January 20–21, 2016 in Bethesda, Maryland.

Announcement 08/26/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held Wednesday-Thursday, January 20-21, 2016, on the NCI campus. More information will be available later this summer.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to http://grants.nih.gov /grants/guide/ pa-files/ PAR-15-289.html.